MURRAY REPORT✉ Free Email News Alerts← world desk
NEWS   /   WORLD NEWS

New MHRA service to support medicines innovation and strengthen UK manufacturing

Photograph accompanying New MHRA service to support medicines innovation and strengthen UK manufacturing (source: UK Government)
UK Government — publisher photograph (see original for photographer credit)

AdvanceGxP will give developers earlier practical support for advanced manufacturing technologies, accelerating patient access to innovative medicines while strengthening UK manufacturing.

Science, Innovation and Investment Minister Chris McDonald MP announcing the Advance GxP service during his closing keynote at the DIA-MHRA Summit, London.

Companies developing new technologies to make medicines, including personalised treatments made at or near hospitals and clinics, manufacturing in space, and the use of AI, robotics and automation, are set to receive earlier practical support from the Medicines and Healthcare products Regulatory Agency (MHRA) to help promising technologies reach patients sooner.

The MHRA has secured funding from the Office for Life Sciences (OLS) to develop and test AdvanceGxP, announced by Science, Innovation and Investment Minister Chris McDonald MP in his closing speech at the inaugural DIA-MHRA Global Summit in London yesterday (17 November) as part of London Life Sciences Week.

Initially focusing on advanced manufacturing technologies, AdvanceGxP is being developed by the MHRA to help innovators address regulatory and quality questions earlier, reducing the risk of avoidable redesign and delays, and supporting more sustainable approaches.